Headquarters
United States
team size
5 - 9
founded
2012
website
http://acceldx.com/
funding probability score
total disclosed funding
last round valuation estimate
disclosed funding rounds
latest round
latest funding stage
next round estimate
development stage
number of investors
number of competitors
monthly web visits
twitter followers
Offices
United States
HQ address
1401 Forbes Avenue, Pittsburgh, 15219, USA
description
AccelDx’s technology enables patients and healthcare providers to perform lab-quality medical diagnostic tests at any time and any place. The patented pScreen™ platform technology employs a single-use blood test the size of a credit card in tandem with a smartphone application to quickly detect disease-specific biomarker levels. The app can then analyze and transfer the results to the patient’s healthcare provider immediately.

AccelDx’s initial product is for Congestive Heart Failure (HF). Re-hospitalization of patients affected by HF has become a $20+ billion problem. With the pScreen™ system, patients can – for the first time ever – monitor their heart conditions at home. It automatically sends healthcare providers up-to-date information on current, historical, and trending HF biomarker NP (natriuretic peptides) levels. This allows healthcare providers and physicians to monitor heart distress levels and prevent HF-related life threatening events and costly re-hospitalizations.

There is much more to this profile.
Log in or sign up for free to see the whole thing.

Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats